La dengue

L’épidémie de dengue déclarée en Nouvelle-Calédonie

La Nouvelle-Calédonie a été déclarée, mercredi 25 mai, en situation d’épidémie de dengue, en raison de la multiplication et de la propagation de la maladie dans l’archipel. « Le foyer de sérotype 1, qui a débuté le 26 janvier dans les quartiers du faubourg Blanchot, à Nouméa, persiste et s’étend progressivement. Deux cents cas ont été répertoriés à la date du 24 mai, dont 16 cas confirmés », a détaillé le gouvernement local dans un communiqué.

Fresh case of dengue fever in Kottakal, health dept steps up vector-control activities

Malappuram: Following reports of dengue fever in Kottakkal, the health department has stepped up vector-control activities in the region.
Recently cases of dengue were reported from Vattamkulam panchayat. Jaundice was also confirmed in over 20 persons in Palappra, Muthur, Vellaparamba and Kavupra, which border Vattamkulam.

Beyond Ebola, keeping patients and health workers safe

Dr Doussou Touré arrives for work at Coléah Medical Centre. She washes her hands from a bucket set up in front of the building, proceeds to a screening area where her temperature is checked and recorded and only then enters the bustling facility that she supervises.
“Ebola is under control now, but we try to keep up the infection prevention and control systems that were put in place during the outbreak,” Dr Touré says, pointing to several sturdy, brightly-coloured bins, each one designated for the disposal of varying waste matter.

Expertos de la OMS recomiendan uso de vacuna Sanofi contra el dengue en países endémicos

Un comité de expertos de la Organización Mundial de la Salud (OMS) recomendó el uso de la vacuna contra el dengue elaborada por el laboratorio francés Sanofi en los países donde el virus es endémico.

Thailand braces for major increase in cases of dengue fever as efforts to deliver vaccine accelerate

The number of dengue cases in Thailand is expected to spike this year, a researcher said, as experts from across Asia met to discuss introduction of the first ever dengue vaccine to control and prevent the disease.
Dengue – which causes flu-like symptoms and can develop into the deadly dengue haemorrhagic fever – is the world’s fastest-spreading tropical disease, with the annual number of cases increasing 30-fold in the last 50 years, according to the World Health Organisation (WHO).

First Dengue Fever Vaccine Gets Green Light in 3 Countries

When female Aedes Aegypti mosquito sups on the blood of its human victims it too often deposits the virus that causes dengue, causing as many as 400 million infections per year worldwide. Severe forms of the painful, flu-like disease can be fatal, especially among children. And until recently there has been no truly effective prevention except avoiding getting bit.
But the outlook against the disease is looking better.

Brazil Grapples With Spread of Zika Virus and Dengue Fever

The mosquito-borne Zika virus continues to spread in Brazil, alarming health officials and raising fresh fears that more newborns will be afflicted with abnormal brain development from the disease.
Meanwhile, cases of another mosquito-transmitted illness, dengue fever, have reached a historical high here in South America’s largest country, with nearly 1.6 million people infected in the past year.

Sanofi lance son vaccin contre la dengue

Enfin une bonne nouvelle pour Sanofi. Embarrassé depuis des mois par les contre-performances de sa division diabète, le groupe pharmaceutique tricolore a annoncé, mercredi 9 décembre, avoir reçu le feu vert des autorités mexicaines pour commercialiser son vaccin contre la dengue, une maladie tropicale transmise par les moustiques.

First Dengue Fever Vaccine Approved by Mexico

A dengue fever vaccine developed by the French pharmaceutical giant Sanofi has been approved for use by Mexico, the first approval in the world for any vaccine for the disease, which afflicts tens of millions of people around the world and is becoming an increasing threat.
Sanofi said in a news release Wednesday that the vaccine, which it is calling Dengvaxia, was approved by Mexico’s Federal Commission for the Protection against Sanitary Risk for prevention of dengue in people 9 to 45 years old living in endemic areas.

Sanofi wins first dengue vaccine market approval in Mexico

Sanofi's dengue vaccine is to make its market debut in Mexico, the French drugmaker said on Wednesday, adding that it expects to have filed for market approval in some 20 countries by year-end.
Sanofi Pasteur, the group's vaccines division, said Mexico had approved the preventive treatment, called Dengvaxia, for all four dengue virus serotypes, but only for patients aged 9 to 45 who live in areas where the disease is endemic.